Norris Medicines Key Metrics

BSE: 524414 | NSE: - | ISIN: INE744C01029 | Sector: Biotechnology & Drugs

18.47 -0.97 (-4.99%)Updated : 26 Nov 2024

Ratios

Return on average equity - 5 year average	-
Net Income/employee - trailing 12 month	-
Revenue/employee - most recent fiscal year	-
Return on investment - most recent fiscal year	-21.69
Return on average assets - most recent fiscal year	-8.52
Receivables turnover - most recent fiscal year	5.22
Return on investment - trailing 12 month	-17.80
Return on average assets - trailing 12 month	-6.30
Inventory turnover - most recent fiscal year	0.71
Inventory turnover - trailing 12 month	0.40
Revenue/employee - trailing 12 month	-
Return on average assets - 5 year average	-16.38
Net Income/employee - most recent fiscal year	-
Return on average equity - trailing 12 month	-
Receivables turnover - trailing 12 month	4.58
Asset turnover - most recent fiscal year	0.40
Asset turnover - trailing 12 month	0.32
Return on average equity - most recent fiscal year	-
Return on investment - 5 year average	-33.12